2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Goel David E. | 10% Owner | 13,959,973 | Jun 20, 2023 |
| Matrix Capital Management Company, LP | 10% Owner | 13,959,973 | Jun 20, 2023 |
| WALTERS GROUP | 10% Owner | 7,050,000 | Jan 8, 2026 |
| WALTERS WILLIAM THURMAN | 10% Owner | 7,050,000 | Jan 8, 2026 |
| WALTERS SUSAN BERKLEY | 10% Owner | 7,050,000 | Jan 8, 2026 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Feb 10, 2026 | Bruns Ingmar | Chief Medical Officer | Sell | 47.5 | -3,297 | -9.00% | ✗ | $8K |
| Feb 6, 2026 | Feb 10, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 16.3 | -40,224 | -21.54% | ✓ | $97.6K |
| Feb 6, 2026 | Feb 10, 2026 | EASTLAND JULIA MARIE | CEO | Sell | 46.3 | -8,755 | -9.96% | ✗ | $21.2K |
| Feb 2, 2026 | Feb 4, 2026 | Vultaggio Vincent | PAO and PFO | Sell | 48.8 | -3,096 | -1.63% | ✓ | $7.9K |
| Jan 8, 2026 | Jan 9, 2026 | Vultaggio Vincent | PAO and PFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2026 | Jan 9, 2026 | Bucher James B | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2026 | Jan 9, 2026 | Bruns Ingmar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2026 | Jan 9, 2026 | EASTLAND JULIA MARIE | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 31, 2025 | Jan 8, 2026 | WALTERS GROUP | 10% Owner | Buy | 100.0 | +6,459,973 | 91.63% | ✗ | $7.8M |
| Jan 8, 2026 | WALTERS GROUP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 15, 2025 | Dec 15, 2025 | Matrix Capital Management Company, LP | 10% Owner | Sell | 16.3 | -7,500,000 | -53.73% | ✗ | $10M |
| Oct 1, 2025 | Oct 1, 2025 | Bucher James B | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 22, 2025 | Bucher James B | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 17, 2025 | Jun 18, 2025 | Walker Luke Nathaniel | Director | Neutral | 90.0 | +57,603 | 66.45% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Skvarka Jan | Director | Neutral | 90.0 | +57,603 | 38.52% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Johnson David Michael | Director | Neutral | 90.0 | +57,603 | 29.87% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Kariuki Enoch | Director | Neutral | 90.0 | +57,603 | 72.22% | ✗ | - |
| Jun 17, 2025 | Jun 18, 2025 | Myers Scott Dunseth | Director | Neutral | 90.0 | +57,603 | 20.49% | ✗ | - |
| Apr 30, 2025 | Apr 30, 2025 | Myers Scott Dunseth | Director | Buy | 86.3 | +21,000 | 8.07% | ✗ | $29.4K |
| Feb 6, 2025 | Feb 12, 2025 | Bruns Ingmar | Chief Medical Officer | Buy | 91.3 | +20,000 | 120.27% | ✗ | $45.7K |
| Feb 3, 2025 | Feb 5, 2025 | Vultaggio Vincent | PAO and Interim PFO | Sell | 90.0 | +155,971 | 460.70% | ✗ | $4.5K |
| Feb 3, 2025 | Feb 5, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 91.3 | +321,539 | 168.07% | ✗ | $24.6K |
| Feb 3, 2025 | Feb 5, 2025 | Paul Andrea | Chief Legal Officer | Sell | 91.3 | +920,811 | 613.98% | ✗ | $22.6K |
| Feb 3, 2025 | Feb 5, 2025 | Bruns Ingmar | Chief Medical Officer | Neutral | 90.0 | +16,629 | 100.00% | ✗ | - |
| Feb 3, 2025 | Feb 5, 2025 | EASTLAND JULIA MARIE | CEO | Neutral | 90.0 | +59,388 | 208.38% | ✗ | - |
| Jan 31, 2025 | Feb 4, 2025 | Skvarka Jan | Director | Buy | 95.0 | +60,000 | 67.00% | ✗ | $103.4K |
| Jan 31, 2025 | Feb 4, 2025 | Walker Luke Nathaniel | Director | Buy | 91.3 | +14,200 | 19.59% | ✗ | $25K |
| Jan 31, 2025 | Feb 4, 2025 | EASTLAND JULIA MARIE | CEO | Buy | 91.3 | +28,500 | 100.00% | ✗ | $49.3K |
| Jan 2, 2025 | Jan 3, 2025 | Lackner Mark | Chief Scientific Officer | Sell | 46.3 | -4,411 | -2.25% | ✗ | $13.8K |
| Dec 2, 2024 | Dec 3, 2024 | Bruns Ingmar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 2, 2024 | Dec 3, 2024 | EASTLAND JULIA MARIE | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 13, 2024 | Myers Scott Dunseth | Director | Neutral | 90.0 | +260,192 | 100.00% | ✗ | - |
| Nov 13, 2024 | Bruns Ingmar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 13, 2024 | EASTLAND JULIA MARIE | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 13, 2024 | Myers Scott Dunseth | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 4, 2024 | Oct 4, 2024 | Vultaggio Vincent | Principal Accounting Officer | Sell | 42.5 | -1,603 | -4.52% | ✓ | $5.1K |
| Jun 21, 2024 | Jun 21, 2024 | Skvarka Jan | Director | Neutral | 90.0 | +41,581 | 86.68% | ✗ | - |
| Jun 21, 2024 | Jun 21, 2024 | Kariuki Enoch | Director | Neutral | 90.0 | +41,581 | 108.90% | ✗ | - |
| Jun 21, 2024 | Jun 21, 2024 | Johnson David Michael | Director | Neutral | 90.0 | +48,429 | 33.54% | ✗ | - |
| May 31, 2024 | May 31, 2024 | Gallagher Cam | CFO | Sell | 45.0 | -9,597 | -1.49% | ✓ | $115K |
| May 24, 2024 | May 29, 2024 | Walker Luke Nathaniel | Director | Neutral | 90.0 | +72,481 | 100.00% | ✗ | - |
| May 29, 2024 | Walker Luke Nathaniel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 9, 2024 | May 9, 2024 | HAUSMAN DIANA | Chief Medical Officer | Sell | 48.8 | -3,356 | -0.89% | ✗ | $42.4K |
| Apr 11, 2024 | Vultaggio Vincent | Principal Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 12, 2024 | Feb 12, 2024 | Epperly Melissa B, | CFO | Sell | 51.3 | -2,573 | -0.57% | ✓ | $29.4K |
| Feb 12, 2024 | Feb 12, 2024 | Gallagher Cam | President | Sell | 53.8 | -1,173 | -0.18% | ✓ | $13.4K |
| Feb 1, 2024 | Feb 5, 2024 | HAUSMAN DIANA | Chief Medical Officer | Neutral | 90.0 | +337,500 | 849.44% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Lackner Mark | Chief Scientific Officer | Sell | 91.3 | +139,415 | 247.57% | ✗ | $18.3K |
| Feb 1, 2024 | Feb 5, 2024 | Paul Andrea | Chief Legal Officer | Sell | 91.3 | +109,190 | 267.73% | ✗ | $38.2K |
| Feb 1, 2024 | Feb 5, 2024 | Gallagher Cam | President | Sell | 95.0 | +180,948 | 39.04% | ✓ | $133.3K |
| Feb 1, 2024 | Feb 5, 2024 | Epperly Melissa B, | CFO | Sell | 95.0 | +66,331 | 17.11% | ✓ | $100K |
| Feb 1, 2024 | Feb 5, 2024 | Blackwell Kimberly | CEO | Sell | 95.0 | +229,345 | 90.01% | ✗ | $241.5K |
| Jan 2, 2024 | Jan 3, 2024 | Lackner Mark | Chief Scientific Officer | Neutral | 90.0 | +40,000 | 245.20% | ✗ | - |
| Jan 3, 2024 | Lackner Mark | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 20, 2023 | Dec 21, 2023 | Bunker Kevin D. | Chief Scientific Officer | Neutral | 27.5 | -24,158 | -2.76% | ✗ | - |
| Nov 10, 2023 | Nov 13, 2023 | Johnson David Michael | Director | Buy | 95.0 | +17,000 | 13.34% | ✗ | $167.9K |
| Nov 13, 2023 | Nov 13, 2023 | Blackwell Kimberly | CEO | Buy | 82.5 | +5,000 | 2.00% | ✗ | $51.4K |
| Oct 4, 2023 | Oct 6, 2023 | Brownstein Carrie | Chief Medical Officer | Sell | 28.8 | -10,628 | -9.14% | ✓ | $207.3K |
| Oct 4, 2023 | Oct 6, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 47.5 | -6,068 | -0.69% | ✓ | $118.4K |
| Oct 4, 2023 | Oct 6, 2023 | Epperly Melissa B, | CFO | Sell | 45.0 | -5,482 | -1.39% | ✓ | $106.9K |
| Sep 11, 2023 | Sep 13, 2023 | Skvarka Jan | Director | Sell | 28.8 | -5,000 | -9.44% | ✓ | $125.2K |
| Jun 20, 2023 | Jun 20, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy | 100.0 | +4,760,000 | 51.74% | ✗ | $107.9M |
| Jun 16, 2023 | Jun 16, 2023 | Johnson David Michael | Director | Neutral | 90.0 | +19,059 | 17.59% | ✗ | - |
| Jun 16, 2023 | Jun 16, 2023 | Kariuki Enoch | Director | Neutral | 90.0 | +16,364 | 75.01% | ✗ | - |
| Jun 16, 2023 | Jun 16, 2023 | Skvarka Jan | Director | Neutral | 90.0 | +16,364 | 44.70% | ✗ | - |
| May 31, 2023 | May 31, 2023 | Gallagher Cam | President | Sell | 30.0 | -27,768 | -5.65% | ✓ | $729.5K |
| May 26, 2023 | May 31, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 23.8 | -80,000 | -8.33% | ✓ | $2.4M |
| May 8, 2023 | May 10, 2023 | HAUSMAN DIANA | Director | Neutral | 90.0 | +39,732 | 100.00% | ✗ | - |
| May 10, 2023 | HAUSMAN DIANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 1, 2023 | Mar 2, 2023 | Roth Iris | COO | Neutral | 90.0 | +52,500 | 100.00% | ✗ | - |
| Feb 13, 2023 | Feb 14, 2023 | Epperly Melissa B, | CFO | Sell | 45.0 | -7,851 | -1.96% | ✓ | $158K |
| Feb 13, 2023 | Feb 14, 2023 | Gallagher Cam | President | Sell | 41.3 | -11,833 | -2.35% | ✓ | $237.8K |
| Feb 13, 2023 | Feb 14, 2023 | Bunker Kevin D. | Chief Scientific Officer | Sell | 45.0 | -10,307 | -1.06% | ✓ | $207.6K |
| Feb 13, 2023 | Roth Iris | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 6, 2023 | Feb 6, 2023 | Gallagher Cam | President | Sell | 45.0 | -10,000 | -1.95% | ✓ | $222.7K |
| Nov 9, 2022 | Feb 1, 2023 | Bunker Kevin D. | Chief Scientific Officer | Neutral | 85.0 | +61,354 | 6.75% | ✗ | - |
| Feb 1, 2023 | Feb 1, 2023 | Gallagher Cam | President | Neutral | 90.0 | +161,092 | 45.76% | ✗ | - |
| Feb 1, 2023 | Feb 1, 2023 | Blackwell Kimberly | CEO | Neutral | 90.0 | +244,800 | 4896.00% | ✗ | - |
| Feb 1, 2023 | Feb 1, 2023 | Epperly Melissa B, | CFO | Neutral | 90.0 | +101,957 | 34.22% | ✗ | - |
| Feb 1, 2023 | Feb 1, 2023 | Paul Andrea | General Counsel | Neutral | 90.0 | +40,783 | 100.00% | ✗ | - |
| Feb 1, 2023 | Feb 1, 2023 | Brownstein Carrie | Chief Medical Officer | Neutral | 90.0 | +16,313 | 16.31% | ✗ | - |
| Jan 17, 2023 | Jan 18, 2023 | Gallagher Cam | President | Sell | 41.3 | -10,000 | -2.76% | ✓ | $241.5K |
| Jan 5, 2023 | Jan 5, 2023 | Gallagher Cam | President | Sell | 41.3 | -10,000 | -2.69% | ✓ | $210.2K |
| Nov 15, 2022 | Nov 15, 2022 | Gallagher Cam | President | Sell | 35.0 | -12,500 | -3.25% | ✓ | $284.7K |
| Nov 7, 2022 | Nov 8, 2022 | Gallagher Cam | President | Sell | 30.0 | -24,874 | -6.08% | ✓ | $587.4K |
| Oct 17, 2022 | Oct 17, 2022 | Gallagher Cam | President | Sell | 38.8 | -12,500 | -2.96% | ✓ | $293.9K |
| Oct 5, 2022 | Oct 7, 2022 | Gallagher Cam | President | Sell | 30.0 | -22,500 | -5.06% | ✓ | $505.2K |
| Oct 3, 2022 | Oct 3, 2022 | Epperly Melissa B, | CFO | Neutral | 90.0 | +50,000 | 20.20% | ✗ | - |
| Oct 3, 2022 | Oct 3, 2022 | Bunker Kevin D. | Chief Scientific Officer | Neutral | 85.0 | +50,000 | 5.82% | ✗ | - |
| Oct 3, 2022 | Oct 3, 2022 | Brownstein Carrie | Chief Medical Officer | Neutral | 90.0 | +100,000 | 100.00% | ✗ | - |
| Oct 3, 2022 | Brownstein Carrie | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 15, 2022 | Sep 16, 2022 | Gallagher Cam | President | Sell | 35.0 | -22,500 | -4.82% | ✓ | $560.3K |
| Sep 9, 2022 | Sep 12, 2022 | Skvarka Jan | Director | Neutral | 90.0 | +36,606 | 100.00% | ✗ | - |
| Sep 12, 2022 | Skvarka Jan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 10, 2022 | Aug 12, 2022 | Bunker Kevin D. | COO | Sell | 47.5 | -5,000 | -0.58% | ✓ | $150K |
| Aug 1, 2022 | Aug 1, 2022 | Paul Andrea | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2022 | Paul Andrea | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 20, 2022 | Jul 20, 2022 | Bunker Kevin D. | COO | Sell | 47.5 | -5,000 | -0.58% | ✓ | $150K |
| Jul 13, 2022 | Jul 14, 2022 | Bunker Kevin D. | COO | Sell | 47.5 | -5,000 | -0.57% | ✓ | $150.1K |
| Jul 5, 2022 | Jul 6, 2022 | Bunker Kevin D. | COO | Sell | 38.8 | -25,000 | -2.78% | ✓ | $751.7K |